Skip to main content
OpenTrials

Clinical trial condition

Pancreatic Ductal Adenocarcinoma

Explore clinical trials studying Pancreatic Ductal Adenocarcinoma. Study availability and eligibility vary by location and protocol.

181 public trials 74 recruiting studies
Refine in advanced search Browse all conditions

Pancreatic Ductal Adenocarcinoma trial results

Completed

CT Pancreas Perfusion

NCT00588367

Conditions
Adenocarcinoma, Alcohol-Induced Disorders, Alcohol-Related Disorders, +29 more
Locations
  • Mayo Clinic Rochester, Minnesota, United States
View Trial Details
Active, Not Recruiting

A Study to Assess IPN01194 When Administered Alone in Adults With Advanced Solid Tumours

NCT06305247

Conditions
Carcinoma, Carcinoma, Squamous Cell, Colonic Diseases, +27 more
Locations
  • The Angeles Clinic and Research Institute - California Los Angeles, California, United States
  • Yale Cancer Center - New Heaven New Haven, Connecticut, United States
  • Sarah Cannon Research Institute (SCRI) - Nashville Nashville, Tennessee, United States
  • Virginia Cancer Specialist Fairfax, Virginia, United States
View Trial Details
Active, Not Recruiting

A Study to Evaluate ATP150/ATP152/ATP162, VSV-GP154 and Ezabenlimab in Patients With Pancreatic Ductal Adenocarcinoma

NCT05846516

Conditions
Pancreatic Ductal Adenocarcinoma
Locations
  • University of Southern California Los Angeles, California, United States
  • University of California Los Angeles Santa Monica, California, United States
  • University of Colorado Cancer Center Aurora, Colorado, United States
  • University of Florida Gainesville, Florida, United States
View all 20 locations
View Trial Details
Active, Not Recruiting

A Study of the Pan-KRAS Inhibitor LY4066434 in Participants With KRAS Mutant Solid Tumors

NCT06607185

Conditions
Adenocarcinoma, Adnexal Diseases, Advanced Solid Tumor, +53 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Mayo Clinic Phoenix, Arizona, United States
  • City of Hope Duarte, California, United States
  • University of California, Los Angeles (UCLA) Santa Monica, California, United States
View all 45 locations
View Trial Details
Active, Not Recruiting

A Study of ELI-002 7P in Subjects With KRAS/NRAS Mutated Solid Tumors

NCT05726864

Conditions
Colonic Diseases, Colonic Neoplasms, Colorectal Cancer, +24 more
Locations
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • Mayo Clinic Comprehensive Cancer Center Phoenix, Arizona, United States
  • City of Hope Duarte, California, United States
  • Cedars-Sinai Medical Center Los Angeles, California, United States
View all 28 locations
View Trial Details
Active, Not Recruiting

ACCENT: AMP945 in Combination With Nab-paclitaxel and Gemcitabine for Treatment of Pancreatic Cancer

NCT05355298

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +8 more
Locations
  • GenesisCare St Leonards, New South Wales, Australia
  • Calvary Mater Newcastle Waratah, New South Wales, Australia
  • Westmead Hospital Westmead, New South Wales, Australia
  • Gallipolli Medical Research Foundation Greenslopes, Queensland, Australia
View all 13 locations
View Trial Details
Active, Not Recruiting

A Phase 1, Dose-escalation Study of [225Ac]-FPI-2068 in Adult Patients With Advanced Solid Tumours

NCT06147037

Conditions
Adenocarcinoma, Advanced Solid Tumor, Bronchial Neoplasms, +42 more
Locations
  • Research Site Palo Alto, California, United States
  • Research Site Chicago, Illinois, United States
  • Research Site Omaha, Nebraska, United States
  • Research Site Cleveland, Ohio, United States
View Trial Details

Related conditions